APIM THERAPEUTICS AS

7034 TRONDHEIM

Finances

Share Ownership

Return on Equity

−41,27 %

Current Ratio

3,54

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	104 000	0	0	0
Net Income	−26 357 000	−14 836 000	−11 769 000	−6 303 000
Total Assets	72 821 000	79 305 000	35 388 000	37 152 000
Total Equity	63 869 000	76 703 000	23 157 000	34 927 000

Income (NOK)	2022	2021	2020	2019
Revenue	104 000	0	0	0
Expenditure	26 931 000	14 768 000	12 264 000	6 519 000
Operating Profit	−26 827 000	−14 767 000	−12 264 000	−6 519 000
Financial Income	789 000	460 000	510 000	223 000
Financial Costs	318 000	530 000	15 000	8 000
Financial Balance	471 000	−70 000	495 000	215 000
Earnings Before Tax	−26 357 000	−14 836 000	−11 769 000	−6 303 000
Tax	0	0	0	0
Net Income	−26 357 000	−14 836 000	−11 769 000	−6 303 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	41 100 000	31 441 000	18 585 000	14 773 000
Total Current Assets	31 721 000	47 865 000	16 803 000	22 379 000
Total Assets	72 821 000	79 305 000	35 388 000	37 152 000
Total Retained Equity	0	0	0	0
Total Equity	63 869 000	76 703 000	23 157 000	34 927 000
Total Long-Term Debt	0	0	10 000 000	0
Total Current Debt	8 952 000	2 602 000	2 231 000	2 226 000
Total Equity and Debt	72 821 000	79 305 000	35 388 000	37 152 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	104 000	0	0	0
Revenue	104 000	0	0	0
Cost of Goods Sold	6 697 000	1 175 000	2 634 000	1 811 000
Salary Costs	1 880 000	1 843 000	1 903 000	1 043 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	26 931 000	14 768 000	12 264 000	6 519 000
Operating Profit	−26 827 000	−14 767 000	−12 264 000	−6 519 000
Financial Income	789 000	460 000	510 000	223 000
Financial Costs	318 000	530 000	15 000	8 000
Financial Balance	471 000	−70 000	495 000	215 000
Dividends	0	0	0	0
Net Income	−26 357 000	−14 836 000	−11 769 000	−6 303 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	1 525 000	1 525 000	1 525 000	1 525 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	39 575 000	29 916 000	17 060 000	13 248 000
Total Fixed Assets	41 100 000	31 441 000	18 585 000	14 773 000
Stock	8 241 000	8 517 000	10 080 000	6 725 000
Total Investments	0	0	0	0
Cash, Bank	18 584 000	37 222 000	4 966 000	14 882 000
Total Current Assets	31 721 000	47 865 000	16 803 000	22 379 000
Total Assets	72 821 000	79 305 000	35 388 000	37 152 000
Total Equity	63 869 000	76 703 000	23 157 000	34 927 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	10 000 000	0
Creditors	8 524 000	1 646 000	961 000	443 000
Unpaid Taxes	96 000	130 000	131 000	145 000
Dividends	0	0	0	0
Other Current Debt	332 000	826 000	1 139 000	1 638 000
Total Current Debt	8 952 000	2 602 000	2 231 000	2 226 000
Total Equity and Debt	72 821 000	79 305 000	35 388 000	37 152 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−41,27 %	−19,34 %	−50,82 %	−18,05 %
Debt-to-Equity Ratio	0	0	0,43	0
Operating Profit Margin	−25 795,19 %	-	-	-
Current Ratio	3,54	18,4	7,53	10,05
Quick Ratio	44,61	−8,09	−2,14	−4,97
Equity Ratio	0,88	0,97	0,65	0,94
Gross Profit Margin	−6 339,42 %	-	-	-